Sign in

CIK 0001020214

  • Accelerated filer
Ticker
CERS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680262011
Phone
+1 925-288-6000
Business address
1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
  1. 4 Grant or award Director acquired 60,000 shares (grant or award)
  2. 4 Grant or award Director acquired 60,000 shares (grant or award)
  3. 4 Planned sale Chief Legal Officer sold 49,024 shares at $1.45 ($71,085)
  4. 4 Planned sale Chief Operating Officer sold 75,989 shares at $1.45 ($110,184)
  5. 4 Planned sale President and CEO sold 193,913 shares at $1.45 ($281,174)
  6. 4 Planned sale Chief Financial Officer sold 59,887 shares at $1.45 ($86,836)
  7. 4 Planned sale Chief Medical Officer sold 49,024 shares at $1.45 ($71,085)
  8. 4 Planned sale Chief Legal Officer sold 27,457 shares at $1.50 ($41,131)
  9. 4 Planned sale Chief Operating Officer sold 33,999 shares at $1.50 ($50,931)
  10. 4 Planned sale President and CEO sold 60,984 shares at $1.50 ($91,354)
  11. 4 Planned sale Chief Financial Officer sold 31,148 shares at $1.50 ($46,660)
  12. 4 Planned sale Chief Medical Officer sold 26,139 shares at $1.50 ($39,156)
  13. 4 Planned sale Chief Legal Officer sold 66,292 shares at an average $1.58 ($104,885)
  14. 4 Planned sale Chief Operating Officer sold 10,780 shares at $1.55 ($16,693)
  15. 4 Planned sale President and CEO sold 23,023 shares at $1.55 ($35,651)
  16. 4 Planned sale Chief Financial Officer sold 69,042 shares at an average $1.57 ($108,658)
  17. 4 Planned sale Chief Medical Officer sold 57,546 shares at an average $1.57 ($90,571)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 36 · 701 filings